Business Description
Founded in Copenhagen in 1998, Genmab is a Danish biotechnology company focused on creating antibody-based treatments for cancer and other serious diseases. Its commercial portfolio includes therapies for blood cancers, cervical cancer, multiple myeloma, thyroid eye disease, and relapsing multiple sclerosis, among others. The company has a broad pipeline of experimental treatments targeting additional cancers and conditions such as hemophilia and sickle cell disease, and works alongside major partners including Johnson & Johnson, Pfizer, AbbVie, and Amgen to advance its research and bring new medicines to patients.
